- Home
- BOE vs OFIX Comparison
BOE vs OFIX Comparison
Compare BOE & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BOE | OFIX |
|---|---|---|
| Founded | 2005 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 632.7M | 534.6M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | BOE | OFIX |
|---|---|---|
| Price | $11.34 | $12.49 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $18.25 |
| AVG Volume (30 Days) | 148.9K | ★ 279.6K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 7.30% | N/A |
| EPS Growth | N/A | ★ 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $822,312,000.00 |
| Revenue This Year | N/A | $6.32 |
| Revenue Next Year | N/A | $6.01 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $9.16 | $10.25 |
| 52 Week High | $12.18 | $17.28 |
Technical Indicators
Market Signals| Indicator | BOE | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 26.08 | 35.47 |
| Support Level | $11.12 | $12.33 |
| Resistance Level | $11.39 | $16.13 |
| Average True Range (ATR) | 0.13 | 0.60 |
| MACD | -0.08 | -0.05 |
| Stochastic Oscillator | 19.99 | 19.35 |
Price Performance
Historical ComparisonAbout BOE Blackrock Enhanced Global Dividend Trust of Beneficial Interest
Blackrock Enhanced Global Dividend Trust has an investment objective to provide current income and current gains, with a secondary investment objective of long-term capital appreciation. Further, it focuses on investing in a portfolio of equity securities and utilizing an option writing to seek total return performance and enhance distributions.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.